During the ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop this past September, Godwin Yung and Dooti Roy held a roundtable discussion on increasing Justice, Equity, Diversity, and Inclusion (JEDI) in clinical trials. Here, they share three takeaways from the conversation.
Amstat News
The Membership Magazine of the American Statistical Association